-
1
-
-
47749109823
-
The role of CXC chemokines and their receptors in cancer
-
Vandercappellen J, Van Damme J, Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett, 2008, 267:226-244.
-
(2008)
Cancer Lett
, vol.267
, pp. 226-244
-
-
Vandercappellen, J.1
Van Damme, J.2
Struyf, S.3
-
2
-
-
0032562614
-
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8- induced neutrophil migration
-
White JR., Lee JM, Young PR, et al. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8- induced neutrophil migration. J Biol Chem, 1998, 273: 10095-10098.
-
(1998)
J Biol Chem
, vol.273
, pp. 10095-10098
-
-
White, J.R.1
Lee, J.M.2
Young, P.R.3
-
3
-
-
69549140918
-
-
Chinese-source
-
2003, 39:45-49
-
-
-
-
5
-
-
34547670601
-
ELR +-CXC chemokines and their receptors in early metanephric development
-
Levashova ZB, Sharma N, Timofeeva OA, et al. ELR +-CXC chemokines and their receptors in early metanephric development. J Am Soc Nephrol, 2007, 18:2359-2370.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 2359-2370
-
-
Levashova, Z.B.1
Sharma, N.2
Timofeeva, O.A.3
-
6
-
-
44449175613
-
CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-D0P receptor heterodimer
-
Parenty G, Appelbe S, Milligan G. CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-D0P receptor heterodimer. Biochem J, 2008, 412:245-256.
-
(2008)
Biochem J
, vol.412
, pp. 245-256
-
-
Parenty, G.1
Appelbe, S.2
Milligan, G.3
-
7
-
-
0034327812
-
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR + CXC chemokine-induced angiogenic activity
-
Addison CL, Daniel TO, Burdick MD, et al. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR + CXC chemokine-induced angiogenic activity. J Immunol, 2000, 165: 5269-5277.
-
(2000)
J Immunol
, vol.165
, pp. 5269-5277
-
-
Addison, C.L.1
Daniel, T.O.2
Burdick, M.D.3
-
8
-
-
1342324748
-
Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer
-
Keane MP, Belperio JA, Xue YY, et al. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol, 2004, 172:2853-2860.
-
(2004)
J Immunol
, vol.172
, pp. 2853-2860
-
-
Keane, M.P.1
Belperio, J.A.2
Xue, Y.Y.3
-
9
-
-
34547645193
-
The role of CXCR2 in systemic neovascularization of the mouse lung
-
Sanchez J, Moldobaeva A, McCIintock J, et al. The role of CXCR2 in systemic neovascularization of the mouse lung. J Appl Physiol, 2007, 103:594-599.
-
(2007)
J Appl Physiol
, vol.103
, pp. 594-599
-
-
Sanchez, J.1
Moldobaeva, A.2
McClintock, J.3
-
10
-
-
33845762255
-
Differential calcium signaling in dairy cows with specific CXCR1 genotypes potentially related to interleukin-8 receptor functionality
-
Rambeaud M, Pighetti GM. Differential calcium signaling in dairy cows with specific CXCR1 genotypes potentially related to interleukin-8 receptor functionality. Immunogenetics, 2007, 59: 53-58.
-
(2007)
Immunogenetics
, vol.59
, pp. 53-58
-
-
Rambeaud, M.1
Pighetti, G.M.2
-
11
-
-
34447519933
-
Clinical update: new treatments for age-related macular degeneration
-
DOI 10.1016/S0140-6736(07)61104-0, PII S0140673607611040
-
Wong TY, Liew G, Mitchell P. Clinical update: new treatments for age-related macular degeneration. Lancetm, 2007, 370:204-206. (Pubitemid 47069522)
-
(2007)
Lancet
, vol.370
, Issue.9583
, pp. 204-206
-
-
Wong, T.Y.1
Liew, G.2
Mitchell, P.3
-
12
-
-
54249146562
-
The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice
-
Bento AF, Leite DF, Claudino RF, et al. The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J Leukoc Biol, 2008, 84:1213-1221.
-
(2008)
J Leukoc Biol
, vol.84
, pp. 1213-1221
-
-
Bento, A.F.1
Leite, D.F.2
Claudino, R.F.3
|